Bone turnover markers in patients with inflammatory bowel disease in remission: a cross-sectional comparison of anti-TNFα therapy with conventional maintenance therapy. [PDF]
Front Med (Lausanne)Jarmakiewicz-Czaja S +7 more
europepmc +1 more source
Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment. [PDF]
Int J Mol SciLee KI, Chen JH, Chen KH.
europepmc +1 more source
Sclerostin's role in bone-muscle crosstalk and osteoporosis pathogenesis. [PDF]
Osteoporos SarcopeniaShahid H, Morya VK, Noh KC.
europepmc +1 more source
Primary Biliary Cholangitis-associated Osteoporosis: Contemporary Review of Pathogenesis and Management. [PDF]
J Clin Transl HepatolYang J +8 more
europepmc +1 more source
Modern Strategies for Osteoporosis Therapy: Current Status and Prospects for Targeted Intervention. [PDF]
Int J Mol SciOmelchenko V +6 more
europepmc +1 more source
Circulating Molecular Drivers of Bone Remodeling in Pancreatitis. [PDF]
Clin Transl GastroenterolHill RL +8 more
europepmc +1 more source
The Association of Bone-related Biomarkers With Incident Hip Fracture: A Nested Case-control Study. [PDF]
J Endocr SocCromer SJ +4 more
europepmc +1 more source
Osteocytes: master orchestrators of skeletal homeostasis, remodeling, and osteoporosis pathogenesis. [PDF]
Front Cell Dev BiolWu Y +6 more
europepmc +1 more source
Novel use of bisphosphonates to improve surgical outcomes in experimental bone tuberculosis. [PDF]
World J OrthopPetukhova VV +8 more
europepmc +1 more source
Plasma metabolomic profiles and risk of hip fracture among US individuals: a nested case-control and prospective cohort study. [PDF]
EBioMedicineWu Z +7 more
europepmc +1 more source